Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Theravance Biopharma Inc TBPH

Healthcare Biotechnology
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). Its late-stage investigational once-daily norepinephrine reuptake inhibitor, Ampreloxetine is in the development for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.


NDAQ:TBPH - Post by User

Theravance Biopharma Inc
<< Previous
 Bullboard Posts
User Avatar Image
(10)
•••
  • MikeTesterX
Post by MikeTesteron Aug 01, 2024 2:39pm
46 Views
Post# 36158762

Theravance Biopharma, Inc. (NASDAQ:TBPH) – Executing o

Theravance Biopharma, Inc. (NASDAQ:TBPH) – Executing ohttps://beyondspx.com/2024/08/01/theravance-biopharma-inc-nasdaqtbph-executing-on-key-priorities-to-drive-long-term-value/
<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities